CCCC - C4 Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CCCC is currently covered by 3 analysts with an average price target of $10.54. This is a potential upside of $7.79 (283.27%) from yesterday's end of day stock price of $2.75.

C4 Therapeutics 's activity chart (see below) currently has 70 price targets and 57 ratings on display. The stock rating distribution of CCCC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.21% with an average time for these price targets to be met of 60.55 days.

Highest price target for CCCC is $10, Lowest price target is $7, average price target is $8.33.

Most recent stock forecast was given by ETZER DAROUT from BARCLAYS on 27-Feb-2026. First documented stock forecast 27-Oct-2020.

Currently out of the existing stock ratings of CCCC, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Apr-2022

$7

$3.96 (130.26%)

$5

14 days ago
(27-Feb-2026)

0/8 (0%)

$4.3 (159.26%)

Buy Since 23-Sep-2025

$10

$6.96 (228.95%)

$8

5 months 18 days ago
(23-Sep-2025)

4/6 (66.67%)

$7.41 (286.10%)

147

Buy Since 13-Dec-2023

$8

$4.96 (163.16%)

$12

6 months 9 days ago
(04-Sep-2025)

4/10 (40%)

$5.33 (199.63%)

102

Hold Since 14-Feb-2025

$3.5

$0.46 (15.13%)

$4

1 years 10 days ago
(03-Mar-2025)

1/3 (33.33%)

$1.1 (45.83%)

196

Buy Since 27-Oct-2020

$14

$10.96 (360.53%)

$15

2 years 9 days ago
(04-Mar-2024)

1/3 (33.33%)

$3.32 (31.09%)

29

Show more analysts

Please expand the browser size to see the chart

What is CCCC (C4 Therapeutics ) average time for price targets to be met?

On average it took 60.55 days on average for the stock forecasts to be realized with a an average price target met ratio 36.21

Which analyst has the current highest performing score on CCCC (C4 Therapeutics ) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on CCCC (C4 Therapeutics )?

Derek Archila works at WELLS FARGO and has 2 price targets and 4 ratings on CCCC

Which analyst is the currently most bullish on CCCC (C4 Therapeutics )?

Leah Rush Cann with highest potential upside - $76.14

Which analyst is the currently most reserved on CCCC (C4 Therapeutics )?

Matthew Luchini with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?